Apolipoprotein(a) Gene Accounts for Greater Than 90% of the Variation in Plasma Lipoprotein(a) Concentrations

This study answered, with unusual precision, a question that justifies the modern approach to lipoprotein(a): how much of a person’s Lp(a) level is set by their genes?

By comparing siblings who shared both, one, or neither copy of the apo(a) gene, the investigators showed that the gene itself accounts for more than 90 percent of the variation in plasma Lp(a) — siblings sharing both alleles had nearly identical levels (correlation 0.95), while those sharing none were dissimilar. Most of that genetic effect traced to a structural feature of the gene, the number of “kringle IV” repeats. Lp(a), in short, is almost entirely inherited and largely fixed.

This is the empirical foundation for two clinical principles. First, because Lp(a) is genetically determined and stable through life, a single measurement suffices — no need to recheck it. Second, because diet and exercise barely move it, an elevated Lp(a) calls for managing every other risk factor aggressively rather than hoping lifestyle will lower the number.

We rate the evidence strong. Though the family sample was small, the design was elegant and the conclusion has held firmly for three decades, underpinning how Lp(a) is tested and interpreted today.